ReviewCell death discovery2026
Targeting cell death in Crohn's disease: from mechanisms to medicines.
Review in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Elevated caspase 3 expression correlates with severe inflammation in Crohn's disease.European journal of histochemistry : EJH · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Crohn's disease (CD) is a chronic inflammatory granulomatous disease that can damage the gastrointestinal tract. Existing treatment methods often fail to achieve satisfactory clinical effects. Although the pathogenesis of CD has not been fully elucidated, increasing evidence suggests that programmed cell death plays a key role in disease progression. This article comprehensively reviews 12 different mechanisms of cell death related to the pathogenesis of CD: apoptosis, necroptosis, pyroptosis, parthanatos, ferroptosis, autophagy-dependent cell death, cuproptosis, oxeiptosis, entotic cell death, netotic cell death, lysosome-dependent cell death, and alkaliptosis. On this basis, the article discusses targeted therapeutic strategies to regulate these cell death pathways, with a particular emphasis on their translational potential in clinical applications. Our analysis of existing studies concludes that autophagy, regulated by ATGs, is crucial in CD, and its dysregulation is associated with genetic factors (ATG16L1, IRGM, NOD2) and the mTOR signaling pathway, suggesting that autophagy may serve as a therapeutic target. Apoptosis and pyroptosis mediated by caspases and gasdermin, respectively, as well as ferroptosis and copper death, are all involved in the pathogenesis of CD, highlighting potential therapeutic strategies through the regulation of these pathways and cell death mechanisms (Graphical abstract 1).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.